AGORACOM Small Cap TV - June 20th - Highlights
posted on
Jun 20, 2012 09:21AM
Good morning to you all. Please find enclosed a summary of the breaking small-cap and micro-cap financial news we highlighted on AGORACOM Small Cap TV this morning. It’s June 20th, 2012, and we’ve found 3 great press releases to report on at the open. Another great day for small-cap and micro-cap financial news. To watch the show live every morning at 9:30 AM, visit our front page ... or click on the image below.
Nighthawk Reports Broad Mineralized Envelopes at Colomac Gold Project with Internal Higher Grade Shoots Including 128 M of 1.36 g/t Au, Containing 71.85 M of 2.04 g/t Au and 8.65 M of 6.83 g/t Au
Nighthawk Gold Corp. ("Nighthawk") (TSX Venture: NHK)
is pleased to report drill results of the initial eight holes from its winter program at its 100% owned Colomac property ("Colomac Gold Project") in the Northwest Territories ("NWT"). Two diamond drills were mobilized to site and drilling commenced March 19 on two priority areas. These results confirm the presence of broad mineralized envelopes at the Colomac Gold Project with internal higher grade gold shoots, which provide a favorable indication that shallow, bulk mineable methods may be used.
Highlights:
Nighthawk Gold Corp.
Nighthawk is a Canadian-based exploration company focused on acquiring and developing gold mineral properties in the NWT. Its land position covers 222,203 acres or 900 square kilometres in the Indin Lake Gold Camp, located approximately 220 kilometres north of Yellowknife, NWT.
Last: 0.22Range: 0.41-0.18Market Cap: 19.3 million
Amarillo Gold Drills 133m @ 2.65 g/t Au and 123m @ 1.49 g/t Au, Lavras do Sul Project, Brazil
Amarillo Gold Corp. (TSX VENTURE:AGC)
is pleased to announce the following drill results from the Butia prospect, which is part of the Lavras do Sul project in Rio Grande do Sul, Brazil. Amarillo previously reported the Butia prospect contained an indicated resource of 215,000 ounces of gold from 6.4 MT @ 1.05 g/t Au, and 308,000 ounces of gold inferred resource from 12.9 MT @ 0.74 g/t Au, using a 0.3 g/t cut-off grade, NI 43-101 compliant, as independently determined by Atticus Consulting, August 2010. This current round of drilling was designed to define and expand the known resource through infill drilling, and by targeting new mineralised zones in the larger Butia alteration zone. Assays results from the first eleven holes in this program have been received and the gold intercepts are reported here as shown in Table 1 below.
Drilling in the higher-grade gold zone of the Butia prospect included drill holes LDH-209 which intercepted 133m @ 2.65 g/t Au and LDH-212 which intercepted 123m @ 1.49 g/t Au. Both drill holes filled gaps in the previous drill program pattern that exceeded 50m.
About Amarillo Gold Corp.
Amarillo Gold Corp. is focused on acquisition, discovery, and definition of gold resources in Brazil. The Company's principal projects are the Mara Rosa Project in the state of Goias, and the Lavras do Sul Project in the state of Rio Grande do Sul. The Posse Deposit at Mara Rosa contains 1,174,900 ounces of measured and indicated gold contained in 20.85 MT at 1.75 g/t Au, and 156,400 ounces of gold inferred from 3.63 MT at 1.38 g/t Au (0.5 g/t cut-off grade) (NI 43-101 compliant resource as independently determined by Australian Exploration Field Services Pty. AEFS). The Mara Rosa Gold Project has received a positive economic assessment from a Pre-feasibility study and is preparing to proceed to a bankable feasibility study. Should this continue to be positive it would be possible to commence mining by 2014.
Last: 0.70Range: 1.65-0.65Market Cap: 45 million
China Botanic Reports Second Quarter Fiscal Year 2012 Results
China Botanic Pharmaceutical Inc. (NYSE AMEX: CBP) ("China Botanic" or the "Company"), a developer, manufacturer and distributor of botanical products, bio-pharmaceuticals and Traditional Chinese Medicines ("TCM") in China, today announced financial results for the three months ended April 30, 2012.
Second Quarter Fiscal 2012 Highlights
Net sales increased 22.0% year over year to $23.0 million
Gross profit increased 13.4% year over year to $12.6 million with gross margin of 54.9%
Net income rose 10.9% to $7.9 million, or $0.21 per diluted share, from $7.1 million, or $0.19 per diluted share, in the second quarter of fiscal 2011
Six Months Fiscal 2012 Highlights
Net sales increased 23.3% year over year to $51.2 million
Gross profit increased 20.0% year over year to $30.0 million with gross margin of 58.5%
Net income rose 11.8% to $20.2 million, or $0.54 per diluted share, from $18.0 million, or $0.48 per diluted share, in the second quarter of fiscal 2011
ABOUT CHINA BOTANIC PHARMACEUTICAL INC.
China Botanic Pharmaceutical Inc. is engaged in the research, development, manufacturing, and distribution of botanical products, bio-pharmaceutical products, and traditional Chinese medicines ("TCM"), in the People's Republic of China. All of the Company's products are produced at its three GMP-certified production facilities in Ah City, Dongfanghong and Qingyang. The Company distributes its botanical anti-depression and nerve-regulation products, biopharmaceutical products, and botanical antibiotic and OTC TCMs through its network of over 3,000 distributors and over 70 sales centers across 24 provinces in China.
Last Trade: 0.689 52 Week: 1.42 – 0.48 Market Cap: 25.69 Million